Figure 3
Staining patterns after therapy. Representative examples of (A) “normal” and (B) “MRD” staining patterns, as well as (C) overt clinical relapse. CD34+CD38− cells are shown by ALDH versus side scatter (SSC). (A) An AML patient (patient 17) with normal cytogenetics, in durable CR exhibiting the “normal” pattern with no detectable CD34+CD38−ALDHint population. The comparison diagnostic pattern for this patient is shown in Figure 1D. (B) An AML patient (patient 1) with Inv16 AML, demonstrating the “MRD” pattern while still in CR; the circled CD34+CD38−ALDHint population was 95% leukemic by FISH. The comparison diagnostic pattern is shown in Figure 1C. (C) A patient (patient 9) with t(8;21) AML, in overt relapse resembling the original diagnostic pattern (shown in Figure 1B). The percentages of CD34+CD38− cells composed of the CD34+CD38−ALDHint and CD34+CD38−ALDHhigh populations are listed on each dot plot.

Staining patterns after therapy. Representative examples of (A) “normal” and (B) “MRD” staining patterns, as well as (C) overt clinical relapse. CD34+CD38 cells are shown by ALDH versus side scatter (SSC). (A) An AML patient (patient 17) with normal cytogenetics, in durable CR exhibiting the “normal” pattern with no detectable CD34+CD38ALDHint population. The comparison diagnostic pattern for this patient is shown in Figure 1D. (B) An AML patient (patient 1) with Inv16 AML, demonstrating the “MRD” pattern while still in CR; the circled CD34+CD38ALDHint population was 95% leukemic by FISH. The comparison diagnostic pattern is shown in Figure 1C. (C) A patient (patient 9) with t(8;21) AML, in overt relapse resembling the original diagnostic pattern (shown in Figure 1B). The percentages of CD34+CD38 cells composed of the CD34+CD38ALDHint and CD34+CD38ALDHhigh populations are listed on each dot plot.

Close Modal

or Create an Account

Close Modal
Close Modal